Pfizer ends COVID-19 trial with 95% efficacy, seek emergency-use authorization
Efficacy in adults over 65 years, who are at particular risk from the virus, was over 94%.
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020(photo credit: REUTERS/DADO RUVIC/ILLUSTRATION/FILE PHOTO)ByREUTERS
